Skip to main navigation
Skip to search
Skip to main content
Monash University Home
Help & FAQ
Home
Profiles
Research units
Equipment
Projects
Outputs
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
A Phase 2, multicenter, single-arm, open label study to evaluate the efficacy and safety of AK104 in subjects with recurrent or metastatic cervical cancer
Frentzas, Sophia
(Primary Chief Investigator (PCI))
Medicine Monash Health
Project
:
Research
Overview
Project Details
Status
Active
Effective start/end date
18/06/20
→
17/06/25
View all
View less
Keywords
clinical trial
treatment efficacy
treatment safety
cervical cancer
phase 2 study